Immunization with outer surface protein (Osp) A, but not OspC, provides cross-protection of mice challenged with North American isolates of Borrelia burgdorferi.
about
Crystal structure of outer surface protein C (OspC) from the Lyme disease spirochete, Borrelia burgdorferi.Comparison of protection in rabbits against host-adapted and cultivated Borrelia burgdorferi following infection-derived immunity or immunization with outer membrane vesicles or outer surface protein A.Fitness estimates from experimental infections predict the long-term strain structure of a vector-borne pathogen in the field.Antibodies against a tick protein, Salp15, protect mice from the Lyme disease agentActive and passive immunity against Borrelia burgdorferi decorin binding protein A (DbpA) protects against infection.Molecular analysis of sequence heterogeneity among genes encoding decorin binding proteins A and B of Borrelia burgdorferi sensu lato.Four clones of Borrelia burgdorferi sensu stricto cause invasive infection in humans.Genetic diversity of the outer surface protein C gene of southern Borrelia isolates and its possible epidemiological, clinical, and pathogenetic implications.Specificity of infection-induced immunity among Borrelia burgdorferi sensu lato speciesAccess of antibody or trypsin to an integral outer membrane protein (P66) of Borrelia burgdorferi is hindered by Osp lipoproteins.Conformational nature of the Borrelia burgdorferi B31 outer surface protein C protective epitope.Population dynamics of a naturally occurring heterogeneous mixture of Borrelia burgdorferi clones.Evidence for vaccine synergy between Borrelia burgdorferi decorin binding protein A and outer surface protein A in the mouse model of lyme borreliosis.Conformational nature of the Borrelia burgdorferi decorin binding protein A epitopes that elicit protective antibodiesVariable tick protein in two genomic groups of the relapsing fever spirochete Borrelia hermsii in western North AmericaPresence of multiple variants of Borrelia burgdorferi in the natural reservoir Peromyscus leucopus throughout a transmission season.Genetics of Borrelia burgdorferiVaccination against Lyme disease: past, present, and futureSuccessful vaccination for Lyme disease: a novel mechanism?Approaches toward the directed design of a vaccine against Borrelia burgdorferi.Fundamental processes in the evolutionary ecology of Lyme borreliosis.ospC diversity in Borrelia burgdorferi: different hosts are different niches.Genetic diversity of ospC in a local population of Borrelia burgdorferi sensu stricto.Inferring epitopes of a polymorphic antigen amidst broadly cross-reactive antibodies using protein microarrays: a study of OspC proteins of Borrelia burgdorferiGenetic diversity of Borrelia burgdorferi sensu stricto in Peromyscus leucopus, the primary reservoir of Lyme disease in a region of endemicity in southern Maryland.Antibody-mediated disease remission in the mouse model of lyme borreliosis.Prevention of lyme disease and other tick-borne infectionsBorrelia burgdorferi strain-specific Osp C-mediated immunity in mice.Progress and controversy surrounding vaccines against Lyme disease.Cross-Immunity and Community Structure of a Multiple-Strain Pathogen in the Tick VectorOspC phylogenetic analyses support the feasibility of a broadly protective polyvalent chimeric Lyme disease vaccineBorrelia burgdorferi population dynamics and prototype gene expression during infection of immunocompetent and immunodeficient mice.Public health impact of strain specific immunity to Borrelia burgdorferi.Within-host competition between Borrelia afzelii ospC strains in wild hosts as revealed by massively parallel amplicon sequencingOral Immunization with OspC Does Not Prevent Tick-Borne Borrelia burgdorferi Infection.Vaccination with the variable tick protein of the relapsing fever spirochete Borrelia hermsii protects mice from infection by tick-bite.Experimental infections of the reservoir species Peromyscus leucopus with diverse strains of Borrelia burgdorferi, a Lyme disease agent.Differentiation of reinfection from relapse in recurrent Lyme disease.Construction and analysis of variants of a polyvalent Lyme disease vaccine: approaches for improving the immune response to chimeric vaccinogens.Human Lyme disease vaccines: past and future concerns.
P2860
Q27630239-EE9772A8-38A4-45A8-87F9-99FD60F2EEBDQ33598183-B7625C5E-8780-4837-82FD-0904325A9D58Q33686914-368B3C79-1450-4278-8EA4-949BF6868C3DQ33745554-E2101BD0-C11B-4DCA-8C33-CD4AA34A49E6Q33753858-C4640FCC-2F1D-4F2F-BAB1-05BC0229ABA2Q33767593-DE96A6AF-C301-455F-BACD-47E4F1762079Q33876984-B55F4FBD-FC8C-43FD-8BD9-8F9828F7CC0CQ33959924-C2943A4A-1D2F-4CDD-8DBC-38CD08AE78D0Q33999873-29C322A0-08CF-4DB2-9344-E3C1E62E60D9Q34001101-3CA1F4A8-90F2-4EDE-94C4-4D0C41A14EFBQ34002237-C7CF9799-1EAB-44BB-9398-3CBC6F82771DQ34002359-3D079C63-8FFC-46AA-9AAB-03FA521326A9Q34005057-9CF2D1FA-7D44-494B-AD8D-B1117FC97A15Q34008493-E1056983-8BD5-4EEF-AA5F-5AF28D895D47Q34033356-180B7C6D-B2FD-421C-9528-CEB1686C0A08Q34296826-B5E89F67-3D50-47E3-9D94-F3866567E9ABQ34299547-A379F279-6018-4482-9A65-E7266A51FCA3Q34327726-686DB51F-32C6-42EF-A242-BF5BF9F48992Q34452618-80395E5E-BAD9-4D32-8A3F-FAA84629A3CEQ34543900-5AB031A6-98B7-43EB-AC00-3F6FC19F9183Q34555108-3B6C795D-4046-4EE9-98F1-031DC14143FAQ34569887-28DF58C1-1141-486A-B086-3F799E91CDC4Q34606054-AC15D680-AD09-473B-B142-D55B556A3FA3Q34797227-38160EF5-9E76-45E9-A6DE-5EC7B454F928Q34973946-7CF7949A-AD40-4274-A545-1C58699A4ACCQ34975726-4D829C54-21EE-4E7A-91D9-5C5834BF506CQ35370734-94AF0D43-BD34-4F8A-BB59-9E4364500901Q35558169-E3967FA4-8743-4EF5-8B39-76A329A979ADQ35623307-73155F84-349B-4ACD-8936-E60D398C63DAQ35759726-8D61B302-7EEC-4FF8-905E-10794206C3B7Q35783542-C5C4AB2C-4386-4692-8281-DF9EB784F9DFQ35802349-8EDE6A33-F921-42BA-8F8B-F77A287D5380Q35821802-E1FE0B6C-CCAA-419B-ADB5-0E5E66A13C1AQ35926881-D677C923-2B37-49AF-953E-9C750A31F486Q35962468-104BB054-27BB-4EC3-9540-B72C241A0398Q36200147-A0BAD007-AAFB-46CC-A2BF-59FD86E37247Q36454949-C8005420-82F2-467B-943C-3E0F7F50E698Q36477144-3C6EE90F-BC5F-41A2-B4D7-37939F1BC471Q37228833-50ECEBDA-5F9D-47C6-B661-9D45D6276FFBQ37470590-C28773AD-6732-445F-863E-EACCAEDD48E4
P2860
Immunization with outer surface protein (Osp) A, but not OspC, provides cross-protection of mice challenged with North American isolates of Borrelia burgdorferi.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Immunization with outer surfac ...... lates of Borrelia burgdorferi.
@en
Immunization with outer surfac ...... lates of Borrelia burgdorferi.
@nl
type
label
Immunization with outer surfac ...... lates of Borrelia burgdorferi.
@en
Immunization with outer surfac ...... lates of Borrelia burgdorferi.
@nl
prefLabel
Immunization with outer surfac ...... lates of Borrelia burgdorferi.
@en
Immunization with outer surfac ...... lates of Borrelia burgdorferi.
@nl
P2093
P356
P1476
Immunization with outer surfac ...... lates of Borrelia burgdorferi.
@en
P2093
Crawford M
LeFebvre RB
Probert WS
P304
P356
10.1093/INFDIS/175.2.400
P407
P577
1997-02-01T00:00:00Z